Vistapath

Cambridge, United States Founded: 2016 • Age: 10 yrs
AI and cloud-based pathology processing for diagnosis is facilitated.

About Vistapath

Vistapath is a Healthcare company based in Cambridge (United States) founded in 2016 by Ben Burley and Timothy Spong. It operates as an AI and cloud-based pathology processing for diagnosis is facilitated. Vistapath has raised $13.82 million across 7 funding rounds from investors including NextGen Venture Partners, Moxxie Ventures and First Star Ventures. The company has 6 employees. Its chief executive is Timothy Spong. Vistapath offers products and services including Sentinel. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is Vistapath, Inc. Its competitors include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics and 3 more; 8 of its 8 listed competitors have raised funding.

Company details

Vistapath was founded in 2016 in Cambridge, United States, as a platform focused on AI and cloud technologies for pathology processing. Diagnostic support is provided through automated analysis of medical images and data. Operations center on healthcare technology, with services including workflow optimization for pathologists. The company is led by co-founders Ben Burley and Timothy Spong, who serves as CEO.

  • Headquarters Cambridge, United States
  • Employees 6
  • Founders Ben Burley, Timothy Spong
  • Sectors
    Healthcare
  • Website vistapath.ai
  • Social LinkedIn X
  • Legal Name Vistapath, Inc
Key Metrics
  • Total Equity Funding
    $13.82M (USD)

    in 7 rounds

  • Latest Funding Round
    $4.44M (USD), Seed

    Jul 2023

  • Investors
  • Employee Count
    6

Products & Services of Vistapath

Vistapath offers a comprehensive portfolio of products and services, including Sentinel.

Sentinel
Digital Pathology Platform

End-to-end solution for optimizing lab workflows with AI

Funding Insights of Vistapath

Vistapath has successfully raised a total of $13.82M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $4.44 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $13.82M
  • Total Rounds 7
  • Last Round Seed β€” $4.44M
  • First Round $225,000

    (Jun 2019)

  • Investors Count 3

All 7 funding rounds of Vistapath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2023$4.44MSeed––
–
Jan 2023$1MSeed––
–
Jun 2022$7.42MSeed––
May 2021$100,000Seed––
–
Sep 2020$170,000Seed––
–
Mar 2020$470,000Seed––
–
Jun 2019$225,000Seed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Vistapath

Vistapath has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include NextGen Venture Partners, Moxxie Ventures and First Star Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investments in tech startups are provided by Moxxie Ventures.
–moxxie.vcSan Francisco, United States
Venture capital investments are directed toward multiple sectors.
2011nextgenvp.comBaltimore, United States
Investments in technology startups are made by First Star Ventures.
–firststar.vcCambridge, United States
Premium access

Investor details for Vistapath

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Vistapath

2 people are tracked at Vistapath (2 in leadership); the tracked headcount is 6.

NameRoleGroup
Ben Burley
Co-FounderLeadership
Timothy Spong
Co-Founder & CEOLeadership
Premium access

Complete people profiles for Vistapath

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Vistapath

3 dated milestones of Vistapath across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Vistapath is founded.
  2. Funding First funding round of $225K.
  3. Funding Latest funding round, Seed, of $4.4M.

Competitors of Vistapath

Vistapath has 8 listed competitors in our database, 8 of them funded. They include PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pathai.com2016Boston, United States$254.94M573
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
viz.ai2016San Francisco, United States$251.99M206
AI and cloud-powered software for stroke care coordination is developed.
deepcell.com2015Mountain View, United States$122.99M94
AI-powered single cell classification and isolation technology for clinical research
deciphex.com2017Dublin, Ireland$56.65M–
Digital pathology software is developed for clinical and veterinary productivity.
aignostics.com2018Berlin, Germany$53.89M25
AI-based pathology diagnostic software is provided for medical analysis.
pictorlabs.ai2019Los Angeles, United States$48.83M–
AI-based tools for pathological image analysis are provided to labs.
paige.ai2018New York, United States$241M–
AI-enabled tools for computational pathology and cancer diagnostics are provided.
nekohealth.com2018Stockholm, Sweden$325.38M–
Platform offering solutions for preventive health scans
Premium access

Detailed competitors of Vistapath

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Vistapath (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Vistapath

Premium access

Complete news archive for Vistapath

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vistapath

Vistapath was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Vistapath is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Timothy Spong is the current CEO of Vistapath. They have also founded this company.

Vistapath is a funded company, having raised a total of $13.82M across 7 funding rounds to date. The company's 1st funding round was a Seed of $225K, raised on Jun 2019.

Vistapath has 6 employees.

Vistapath was founded in 2016 in Cambridge, United States, as a platform focused on AI and cloud technologies for pathology processing. Diagnostic support is provided through automated analysis of medical images and data. Operations center on healthcare technology, with services including workflow optimization for pathologists. The company is led by co-founders Ben Burley and Timothy Spong, who serves as CEO.

Vistapath's top competitors include Aignostics, Deciphex and Pictor Labs.

Vistapath offers Sentinel.

Vistapath has 3 investors. Key investors include NextGen Venture Partners, Moxxie Ventures, and First Star Ventures.

Vistapath operates through Vistapath, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available